09/16/2025
5:15 AM | Aardvark Therapeutics (Issuer)
Lee Tien-Li (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2025
3:05 PM | Aardvark Therapeutics (Subject)
Tan Finian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2025
7:28 PM | Aardvark Therapeutics (Issuer)
Lee Tien-Li (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2025
4:36 PM | Aardvark Therapeutics (Issuer)
Sun Nelson (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/02/2025
7:56 PM | Aardvark Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2025
3:05 PM | Aardvark Therapeutics (Issuer)
Lee Tien-Li (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2025
3:36 PM | Aardvark Therapeutics (Subject)
Tan Finian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2025
4:29 PM | Aardvark Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/31/2025
3:45 PM | Aardvark Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
4:55 PM | Aardvark Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SCHEDULE 13G | |
02/24/2025
6:00 AM | Aardvark Therapeutics (Subject)
Tan Finian (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for AARD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/19/2025
4:44 PM | Aardvark Therapeutics (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:57 PM | Aardvark Therapeutics (Issuer)
Chi Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:48 PM | Aardvark Therapeutics (Issuer)
Vickers Venture Fund VI Pte Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:30 PM | Aardvark Therapeutics (Issuer)
Sun Nelson (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:02 PM | Aardvark Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/12/2025
11:15 PM | Aardvark Therapeutics (Filer)
| Form EFFECT | |
02/12/2025
6:47 PM | Aardvark Therapeutics (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:32 PM | Aardvark Therapeutics (Issuer)
Tong Victor Edward Jr (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:07 PM | Aardvark Therapeutics (Issuer)
Jaiman Manasi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:11 PM | Aardvark Therapeutics (Issuer)
Vickers Venture Fund VI Pte Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:17 PM | Aardvark Therapeutics (Issuer)
Graf Susan E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:19 PM | Aardvark Therapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:24 PM | Aardvark Therapeutics (Issuer)
Sun Nelson (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
6:24 PM | Aardvark Therapeutics (Issuer)
Jones Bryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
5:49 PM | Aardvark Therapeutics (Issuer)
Lee Tien-Li (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
5:55 PM | Aardvark Therapeutics (Issuer)
Chi Jeffrey (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
4:18 PM | Aardvark Therapeutics (Issuer)
Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
1:05 PM | Aardvark Therapeutics (Filer)
| Form CERT | |
02/06/2025
3:02 PM | Aardvark Therapeutics (Filer)
| Form S-1/A | |
01/23/2025
3:57 PM | Aardvark Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
